Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Esma
Esma Alanya, Hamburg DE
| Patent application number | Description | Published |
|---|---|---|
| 20110142780 | AGENT FOR KERATIN-CONTAINING FIBERS, COMPRISING AT LEAST ONE PARTICULAR AMPHIPHILIC CATIONIC POLYMER AND AT LEAST ONE POLYMER WITH SILICON-CONTAINING SIDECHAINS AND ANIONIC GROUPS - Agent for treating keratin-containing fibers, particularly, human hair, containing in a cosmetically-acceptable vehicle: (a) at least one amphiphilic, cationic polymer having at least one formula (I) structural unit, at least one formula (II) structural unit, at least one formula (III) structural, and at least one formula (IV) structural unit, where R | 06-16-2011 |
Esma Lejmi, Issy Les Moulineaux FR
| Patent application number | Description | Published |
|---|---|---|
| 20100247520 | MUTATED NETRIN 4, FRAGMENTS THEREOF AND USES THEREOF AS DRUGS - The present invention relates to a protein comprising or consisting of one of the following sequences: the sequence SEQ ID NO: 2 or SEQ ID NO: 4, or a fragment of said sequence represented by one of the sequences SEQ ID NO: 2 | 09-30-2010 |
Esma Lejmi, Villejuif FR
| Patent application number | Description | Published |
|---|---|---|
| 20110262432 | MUTATED NETRIN 4 PROTEINS, FRAGMENTS THEREOF AND THEIR USES AS DRUGS - A mutated protein includes the sequence of wild type netrin 4, represented by SEQ ID NO: 2, wherein at least one amino acid of the amino acids at position (13, 68, 183, 205, 234, 331, 332, 353, 472, 515, 589, 625, 626, 627) and (628) is mutated enabling thus to confer 1 to 15 mutations to the wild type protein, or, truncated protein derived from the mutated protein, wherein the 19 first contiguous, or the 31 first contiguous amino acids at the N-terminus part of the mutated protein are deleted; and/or the mutated protein being deleted of all amino acids located after the amino acid in position (477) or of all amino acids located after the amino acid in position (515). | 10-27-2011 |
Esma Ucisik-Akkaya, Selden, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20100081135 | Single nucleotide polymorphisms and use of same predicting male- specific prenatal loss - The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific prenatal loss of a conceptus or embryo. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk of prenatal loss is also disclosed. | 04-01-2010 |
| 20100092959 | Single nucleotide polymorphisms as genetic markers for childhood leukemia - The present invention is directed to a panel of single nucleotide polymorphisms (SNPs) in specific genes that serve as biomarkers for sex-specific childhood leukemia risk. There is provided herein methods and reagents for assessing the specific SNPs in those genes. The method useful in applying these SNPs in predicting an increased risk or a decreased risk for childhood leukemia for males and females is also disclosed. | 04-15-2010 |